Analyst Ratings For NASDAQ:IDXX – Idexx Laboratories (NASDAQ:IDXX)
Today, Credit Suisse Group raised its price target on NASDAQ:IDXX – Idexx Laboratories (NASDAQ:IDXX) to per share.
Some recent analyst ratings include
- 5/7/2018-Canaccord Genuity Reiterated Rating of Buy ➝ Positive.
- 12/8/2017-Aegis Reiterated Rating of Sell.
- 7/28/2017-CL King Upgrade from a “Neutral ➝ Buy” rating to a “” rating.
Recent Insider Trading Activity For NASDAQ:IDXX – Idexx Laboratories (NASDAQ:IDXX)
NASDAQ:IDXX – Idexx Laboratories (NASDAQ:IDXX) has insider ownership of 2.56% and institutional ownership of 86.14%.
- On 5/30/2018 Jacqueline Studer, VP, sold 475 with an average share price of $209.98 per share and the total transaction amounting to $99,740.50.
- On 5/29/2018 Giovani Twigge, Insider, sold 1,626 with an average share price of $204.37 per share and the total transaction amounting to $332,305.62.
- On 5/10/2018 William T End, Director, sold 9,470 with an average share price of $208.36 per share and the total transaction amounting to $1,973,169.20.
- On 2/28/2018 Daniel M Junius, Director, sold 2,974 with an average share price of $190.06 per share and the total transaction amounting to $565,238.44.
- On 2/22/2018 William T End, Director, sold 4,000 with an average share price of $184.48 per share and the total transaction amounting to $737,920.00.
- On 2/14/2018 Lawrence D Kingsley, Director, bought 1,000 with an average share price of $178.05 per share and the total transaction amounting to $178,050.00.
- On 2/8/2018 Jonathan W Ayers, Chairman, sold 22,000 with an average share price of $177.52 per share and the total transaction amounting to $3,905,440.00.
Recent Trading Activity for NASDAQ:IDXX – Idexx Laboratories (NASDAQ:IDXX)
Shares of NASDAQ:IDXX – Idexx Laboratories closed the previous trading session at 212.52 up +4.31 2.07% with 210.50999450683594 shares trading hands.